Katrina Ramsey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katrina Ramsey has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- David Andrew Dorr
Oregon Health & Science University
2 shared publications - Rachel Lauren Ross
Division of Health Policy and Management, School of Public Health, University of California, Berkeley
2 shared publications - Ana Cecilia Manero
CLIMA-L (Clínica Mexicana de Autismo León), Universidad del Valle de Atemajac, Valle del Mezquital # 101, Colonia del Valle del Campestre, León, Guanajuato, Mexico
1 shared publication - Annette Vu
Oregon Clinical and Translational Research Institute, Oregon Health & Science University , Portland, OR
1 shared publication - Ariana Ba Stuart
Department of Orthopedic Surgery, Oregon Health & Science University, Portland, OR; and
1 shared publication - Benjamin Nealy
Division of Biostatistics, OHSU-PSU School of Public Health, Portland, OR, USA
1 shared publication
Latest Publications
- 26 August 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Remote identification of new-onset paediatric atopic dermatitis: a comparison of diagnostic methods from a post hoc analysis of the CASCADE prevention trial
Background: Few validated diagnostic criteria for atopic dermatitis (AD) can diagnose AD without a clinician’s examination, and even fewer are validated in very young children. Recently, the Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE) prevention trial remotely captured parent and caregiver responses to the Childhood Eczema Questionnaire (CEQ) and a Proxy Report of a Clinician AD Diagnosis (PRC-AD) in children ≤ 2 years of age. Objectives: To evaluate the performance of CEQ and PRC-AD for the purpose of remote AD diagnosis. Methods: Data from the CASCADE trial were used to calculate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CEQ or PRC-AD at 12 and 24 months of age in 933 participants with data available for comparison against the reference standard of a clinician’s chart-diagnosis of AD, present in 26.2% (n = 244/933 at 24 months) of the cohort. Clinicians who acted as the reference standard were primary care clinicians or paediatricians who received additional training in diagnosing AD. Results: PRC-AD displayed sensitivity of 65.8% and 71.6%, and specificity of 91.3% and 93.2% at 12 months and 24 months, respectively. It also displayed PPV of 72.5% and 88.3%, and NPV of 88.5% and 82.2% at 12 and 24 months, respectively. In comparison, CEQ showed sensitivity of 46.3% and 50.9%, and specificity of 91.5% and 93.2% at 12 months and 24 months, respectively. It showed PPV of 64.5% and 84.1%, and NPV of 83.5% and 72.8% at 12 months and 24 months, respectively. A lack of proxy-observed or reported itch or rash were the most common reasons for CEQ false-negative cases. Conclusions: PRC-AD performed well for sensitivity, specificity, PPV and NPV, followed by CEQ. This study based in the USA provides new evidence that supports PRC-AD as an adequate approach to identify eczema cases remotely for research in children ≤ 2 years old with access to healthcare.
- 26 August 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Remote identification of new-onset paediatric atopic dermatitis: a comparison of diagnostic methods from a post hoc analysis of the CASCADE prevention trial
Background: Few validated diagnostic criteria for atopic dermatitis (AD) can diagnose AD without a clinician’s examination, and even fewer are validated in very young children. Recently, the Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE) prevention trial remotely captured parent and caregiver responses to the Childhood Eczema Questionnaire (CEQ) and a Proxy Report of a Clinician AD Diagnosis (PRC-AD) in children ≤ 2 years of age. Objectives: To evaluate the performance of CEQ and PRC-AD for the purpose of remote AD diagnosis. Methods: Data from the CASCADE trial were used to calculate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CEQ or PRC-AD at 12 and 24 months of age in 933 participants with data available for comparison against the reference standard of a clinician’s chart-diagnosis of AD, present in 26.2% (n = 244/933 at 24 months) of the cohort. Clinicians who acted as the reference standard were primary care clinicians or paediatricians who received additional training in diagnosing AD. Results: PRC-AD displayed sensitivity of 65.8% and 71.6%, and specificity of 91.3% and 93.2% at 12 months and 24 months, respectively. It also displayed PPV of 72.5% and 88.3%, and NPV of 88.5% and 82.2% at 12 and 24 months, respectively. In comparison, CEQ showed sensitivity of 46.3% and 50.9%, and specificity of 91.5% and 93.2% at 12 months and 24 months, respectively. It showed PPV of 64.5% and 84.1%, and NPV of 83.5% and 72.8% at 12 months and 24 months, respectively. A lack of proxy-observed or reported itch or rash were the most common reasons for CEQ false-negative cases. Conclusions: PRC-AD performed well for sensitivity, specificity, PPV and NPV, followed by CEQ. This study based in the USA provides new evidence that supports PRC-AD as an adequate approach to identify eczema cases remotely for research in children ≤ 2 years old with access to healthcare.
- 1 November 2023
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 37 (11) , 586-590
Outcomes of Fracture Surgery in Patients With Escalating Hemoglobin A1C in the Setting of Unmanaged Diabetes
Objective: To determine whether there is a threshold of elevated hemoglobin A1C (HbA1c) above which the complication risk is so high that fracture fixation should be avoided. Design: Retrospective cohort study. Setting: Academic Level I trauma center. Patients/Participants: A cohort of 187 patients with HbA1c values >7 and operatively treated extremity fractures. Intervention: Surgical fixation of extremity fractures. Main Outcome Measurements: Rate of major orthopaedic complication (loss of reduction, nonunion, infection, and need for salvage procedure). Results: 34.8% demonstrated HbA1c > 9% and 12.3% with HbA1c > 11. Major complications occurred in 31.4%; HbA1c values were not predictive. We found no evidence of a clinically or statistically significant relationship between HbA1c and risk of major complication. The odds ratio for a one-point increase in HbA1c was 1.006 (P = 0.9439), and the area under the receiver operating characteristic curve, which reflects the average probability that someone with a major complication will have a higher HbA1c than someone without, was 0.51 (95% confidence interval 0.42–0.61), equivalent to random chance. Conclusion: Diabetic patients with fracture demonstrated an extremely high overall rate of complications, with 30.5% experiencing a major complication. However, patients with extreme diabetic neglect did not have higher complication rates after extremity fracture fixation when compared with patients with controlled and uncontrolled diabetes. There was no correlation between rate of complication and level of HbA1c. In addition, there was no difference in complication rate between upper and lower extremity fractures or between fractures treated with open or percutaneous fixation. This suggests that fracture treatment decision-making should not be altered for patients with poor diabetic control, and that surgery is not contraindicated in patients with an extremely high HbA1c. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 November 2023
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 37 (11) , 586-590
Outcomes of Fracture Surgery in Patients With Escalating Hemoglobin A1C in the Setting of Unmanaged Diabetes
Objective: To determine whether there is a threshold of elevated hemoglobin A1C (HbA1c) above which the complication risk is so high that fracture fixation should be avoided. Design: Retrospective cohort study. Setting: Academic Level I trauma center. Patients/Participants: A cohort of 187 patients with HbA1c values >7 and operatively treated extremity fractures. Intervention: Surgical fixation of extremity fractures. Main Outcome Measurements: Rate of major orthopaedic complication (loss of reduction, nonunion, infection, and need for salvage procedure). Results: 34.8% demonstrated HbA1c > 9% and 12.3% with HbA1c > 11. Major complications occurred in 31.4%; HbA1c values were not predictive. We found no evidence of a clinically or statistically significant relationship between HbA1c and risk of major complication. The odds ratio for a one-point increase in HbA1c was 1.006 (P = 0.9439), and the area under the receiver operating characteristic curve, which reflects the average probability that someone with a major complication will have a higher HbA1c than someone without, was 0.51 (95% confidence interval 0.42–0.61), equivalent to random chance. Conclusion: Diabetic patients with fracture demonstrated an extremely high overall rate of complications, with 30.5% experiencing a major complication. However, patients with extreme diabetic neglect did not have higher complication rates after extremity fracture fixation when compared with patients with controlled and uncontrolled diabetes. There was no correlation between rate of complication and level of HbA1c. In addition, there was no difference in complication rate between upper and lower extremity fractures or between fractures treated with open or percutaneous fixation. This suggests that fracture treatment decision-making should not be altered for patients with poor diabetic control, and that surgery is not contraindicated in patients with an extremely high HbA1c. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 25 January 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (4) , 547-555
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection
Patients and clinicians want to know who is protected from SARS-CoV-2 infection. This update is part of a living systematic review to understand the potential value of antibody testing as a correla... Background: The strength and duration of immunity from infection with SARS-CoV-2 are important for public health planning and clinical practice. Purpose: To synthesize evidence on protection agains...
- 25 January 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (4) , 547-555
Open AccessRisk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection
Patients and clinicians want to know who is protected from SARS-CoV-2 infection. This update is part of a living systematic review to understand the potential value of antibody testing as a correla... Background: The strength and duration of immunity from infection with SARS-CoV-2 are important for public health planning and clinical practice. Purpose: To synthesize evidence on protection agains...
- 10 December 2021
- Published by Wolters Kluwer Health in Medical Care
- Vol. 60 (2) , 149-155
The Transforming Outcomes for Patients Through Medical Home Evaluation and reDesign (TOPMED) Cluster Randomized Controlled Trial
Background: Primary Care Medical Home (PCMH) redesign efforts are intended to enhance primary care’s ability to improve population health and well-being. PCMH transformation that is focused on “high-value elements” (HVEs) for cost and utilization may improve effectiveness. Objectives: The objective of this study was to determine if a focus on achieving HVEs extracted from successful primary care transformation models would reduce cost and utilization as compared with a focus on achieving PCMH quality improvement goals. Research Design: A stratified, cluster randomized controlled trial with 2 arms. All practices received equal financial incentives, health information technology support, and in-person practice facilitation. Analyses consisted of multivariable modeling, adjusting for the cluster, with difference-in-difference results. Subjects: Eight primary care clinics that were engaged in PCMH reform. Measures: We examined: (1) total claims payments; (2) emergency department (ED) visits; and (3) hospitalizations among patients during baseline and intervention years. Results: In total, 16,099 patients met the inclusion criteria. Intervention clinics had significantly lower baseline ED visits (P=0.02) and claims paid (P=0.01). Difference-in-difference showed a decrease in ED visits greater in control than intervention (ED per 1000 patients: +56; 95% confidence interval: +96, +15) with a trend towards decreased hospitalizations in intervention (−15; 95% confidence interval: −52, +21). Costs were not different. In modeling monthly outcome means, the generalized linear mixed model showed significant differences for hospitalizations during the intervention year (P=0.03). Discussion: The trial had a trend of decreasing hospitalizations, increased ED visits, and no change in costs in the HVE versus quality improvement arms.
- 10 December 2021
- Published by Wolters Kluwer Health in Medical Care
- Vol. 60 (2) , 149-155
The Transforming Outcomes for Patients Through Medical Home Evaluation and reDesign (TOPMED) Cluster Randomized Controlled Trial
Background: Primary Care Medical Home (PCMH) redesign efforts are intended to enhance primary care’s ability to improve population health and well-being. PCMH transformation that is focused on “high-value elements” (HVEs) for cost and utilization may improve effectiveness. Objectives: The objective of this study was to determine if a focus on achieving HVEs extracted from successful primary care transformation models would reduce cost and utilization as compared with a focus on achieving PCMH quality improvement goals. Research Design: A stratified, cluster randomized controlled trial with 2 arms. All practices received equal financial incentives, health information technology support, and in-person practice facilitation. Analyses consisted of multivariable modeling, adjusting for the cluster, with difference-in-difference results. Subjects: Eight primary care clinics that were engaged in PCMH reform. Measures: We examined: (1) total claims payments; (2) emergency department (ED) visits; and (3) hospitalizations among patients during baseline and intervention years. Results: In total, 16,099 patients met the inclusion criteria. Intervention clinics had significantly lower baseline ED visits (P=0.02) and claims paid (P=0.01). Difference-in-difference showed a decrease in ED visits greater in control than intervention (ED per 1000 patients: +56; 95% confidence interval: +96, +15) with a trend towards decreased hospitalizations in intervention (−15; 95% confidence interval: −52, +21). Costs were not different. In modeling monthly outcome means, the generalized linear mixed model showed significant differences for hospitalizations during the intervention year (P=0.03). Discussion: The trial had a trend of decreasing hospitalizations, increased ED visits, and no change in costs in the HVE versus quality improvement arms.
- Open Access
- 29 September 2020
- Published by MDPI AG in Biosensors
- Vol. 10 (10) , 138
Accuracy of the Dexcom G6 Glucose Sensor during Aerobic, Resistance, and Interval Exercise in Adults with Type 1 Diabetes
The accuracy of continuous glucose monitoring (CGM) sensors may be significantly impacted by exercise. We evaluated the impact of three different types of exercise on the accuracy of the Dexcom G6 sensor. Twenty-four adults with type 1 diabetes on multiple daily injections wore a G6 sensor. Participants were randomized to aerobic, resistance, or high intensity interval training (HIIT) exercise. Each participant completed two in-clinic 30-min exercise sessions. The sensors were applied on average 5.3 days prior to the in-clinic visits (range 0.6–9.9). Capillary blood glucose (CBG) measurements with a Contour Next meter were performed before and after exercise as well as every 10 min during exercise. No CGM calibrations were performed. The median absolute relative difference (MARD) and median relative difference (MRD) of the CGM as compared with the reference CBG did not differ significantly from the start of exercise to the end exercise across all exercise types (ranges for aerobic MARD: 8.9 to 13.9% and MRD: −6.4 to 0.5%, resistance MARD: 7.7 to 14.5% and MRD: −8.3 to −2.9%, HIIT MARD: 12.1 to 16.8% and MRD: −14.3 to −9.1%). The accuracy of the no-calibration Dexcom G6 CGM was not significantly impacted by aerobic, resistance, or HIIT exercise.
- 29 September 2020
- Published by MDPI AG in Biosensors
- Vol. 10 (10) , 138
Open AccessAccuracy of the Dexcom G6 Glucose Sensor during Aerobic, Resistance, and Interval Exercise in Adults with Type 1 Diabetes
The accuracy of continuous glucose monitoring (CGM) sensors may be significantly impacted by exercise. We evaluated the impact of three different types of exercise on the accuracy of the Dexcom G6 sensor. Twenty-four adults with type 1 diabetes on multiple daily injections wore a G6 sensor. Participants were randomized to aerobic, resistance, or high intensity interval training (HIIT) exercise. Each participant completed two in-clinic 30-min exercise sessions. The sensors were applied on average 5.3 days prior to the in-clinic visits (range 0.6–9.9). Capillary blood glucose (CBG) measurements with a Contour Next meter were performed before and after exercise as well as every 10 min during exercise. No CGM calibrations were performed. The median absolute relative difference (MARD) and median relative difference (MRD) of the CGM as compared with the reference CBG did not differ significantly from the start of exercise to the end exercise across all exercise types (ranges for aerobic MARD: 8.9 to 13.9% and MRD: −6.4 to 0.5%, resistance MARD: 7.7 to 14.5% and MRD: −8.3 to −2.9%, HIIT MARD: 12.1 to 16.8% and MRD: −14.3 to −9.1%). The accuracy of the no-calibration Dexcom G6 CGM was not significantly impacted by aerobic, resistance, or HIIT exercise.
- Open Access
- 21 October 2017
- Published by MDPI AG in Healthcare
- Vol. 5 (4) , 78
Perceptions of Risk Stratification Workflows in Primary Care
Risk stratification (RS) in primary care is frequently used by policy-makers, payers, and health systems; the process requires risk assessment for adverse health outcomes across a population to assign patients into risk tiers and allow care management (CM) resources to be targeted effectively. Our objective was to understand the approach to and perception of RS in primary care practices. An online survey was developed, tested, and administered to 148 representatives of 37 primary care practices engaged in RS varying in size, location and ownership. The survey assessed practices’ approach to, perception of, and confidence in RS, and its effect on subsequent CM activities. We examined psychometric properties of the survey to determine validity and conducted chi-square analyses to determine the association between practice characteristics and confidence and agreement with risk scores. The survey yielded a 68% response rate (100 respondents). Overall, participants felt moderately confident in their risk scores (range 41–53.8%), and moderately to highly confident in their subsequent CM workflows (range 46–68%). Respondents from small and independent practices were more likely to have higher confidence and agreement with their RS approaches and scores (p < 0.01). Confidence levels were highest, however, when practices incorporated human review into their RS processes (p < 0.05). This trend was not affected by respondents’ professional roles. Additional work from a broad mixed-methods effort will add to our understanding of RS implementation processes and outcomes.
- 21 October 2017
- Published by MDPI AG in Healthcare
- Vol. 5 (4) , 78
Open AccessPerceptions of Risk Stratification Workflows in Primary Care
Risk stratification (RS) in primary care is frequently used by policy-makers, payers, and health systems; the process requires risk assessment for adverse health outcomes across a population to assign patients into risk tiers and allow care management (CM) resources to be targeted effectively. Our objective was to understand the approach to and perception of RS in primary care practices. An online survey was developed, tested, and administered to 148 representatives of 37 primary care practices engaged in RS varying in size, location and ownership. The survey assessed practices’ approach to, perception of, and confidence in RS, and its effect on subsequent CM activities. We examined psychometric properties of the survey to determine validity and conducted chi-square analyses to determine the association between practice characteristics and confidence and agreement with risk scores. The survey yielded a 68% response rate (100 respondents). Overall, participants felt moderately confident in their risk scores (range 41–53.8%), and moderately to highly confident in their subsequent CM workflows (range 46–68%). Respondents from small and independent practices were more likely to have higher confidence and agreement with their RS approaches and scores (p < 0.01). Confidence levels were highest, however, when practices incorporated human review into their RS processes (p < 0.05). This trend was not affected by respondents’ professional roles. Additional work from a broad mixed-methods effort will add to our understanding of RS implementation processes and outcomes.
- 1 May 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 213 (5) , 906-909
Optimizing physician skill development for medical students: The four-part assessment
- 1 May 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 213 (5) , 906-909
Optimizing physician skill development for medical students: The four-part assessment
- 21 January 2016
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 46 (5) , 1669-1685
Prevalence of Autism Spectrum Disorders in Guanajuato, Mexico: The Leon survey
There are no epidemiological data on autism for Mexico. This study was conducted to generate a first estimate of ASD prevalence in Mexico. We surveyed children age eight in Leon (Guanajuato). The sample was stratified in two strata: (1) children having special education and medical records (SEMR; N = 432) and (2) children attending regular schools (GSS; N = 11,684). GSS children were screened with the SRS and those with the highest scores were invited to a diagnostic evaluation. The final sample comprised 36 children (80.6 % male) who had confirmed ASD. A third had intellectual disability, 25 % were non-verbal, 69 % had co-occurring behavioral problems. The prevalence overall was 0.87 % (95 % CI 0.62, 1.1 %). This survey provides an estimate for ASD prevalence in Mexico that is consistent with recent studies.
- 21 January 2016
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 46 (5) , 1669-1685
Prevalence of Autism Spectrum Disorders in Guanajuato, Mexico: The Leon survey
There are no epidemiological data on autism for Mexico. This study was conducted to generate a first estimate of ASD prevalence in Mexico. We surveyed children age eight in Leon (Guanajuato). The sample was stratified in two strata: (1) children having special education and medical records (SEMR; N = 432) and (2) children attending regular schools (GSS; N = 11,684). GSS children were screened with the SRS and those with the highest scores were invited to a diagnostic evaluation. The final sample comprised 36 children (80.6 % male) who had confirmed ASD. A third had intellectual disability, 25 % were non-verbal, 69 % had co-occurring behavioral problems. The prevalence overall was 0.87 % (95 % CI 0.62, 1.1 %). This survey provides an estimate for ASD prevalence in Mexico that is consistent with recent studies.